EUVIMEDEUVIMED entdecken
Crossref

Probiotic biogenics-mediated augmentation of phage therapy against multidrug-resistant Enterotoxigenic Escherichia coli

Abishek Mani, Nashath Kalangadan, Sharayu Magar, Barath Sivaraj, Gospel Gabriel Xavier, Thirumalai Diraviyam, Srivignesh Sundaresan, Sutharsan Govindarajan, Kaushik Rajaram

AIMS Microbiology · 2026 · 12 (4) · 789-814

DOI: 10.3934/microbiol.2026034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIMS Microbiology, 2026. Verfasst von Abishek Mani und 8 weiteren Autor:innen. Die Arbeit nennt 72 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mani, A., Kalangadan, N., Magar, S., Sivaraj, B., Xavier, G. G., Diraviyam, T., Sundaresan, S., Govindarajan, S., & Rajaram, K. (2026). Probiotic biogenics-mediated augmentation of phage therapy against multidrug-resistant Enterotoxigenic Escherichia coli. AIMS Microbiology, 12(4), 789-814. https://doi.org/10.3934/microbiol.2026034

Vancouver

Mani A, Kalangadan N, Magar S, Sivaraj B, Xavier GG, Diraviyam T, et al. Probiotic biogenics-mediated augmentation of phage therapy against multidrug-resistant Enterotoxigenic Escherichia coli. AIMS Microbiology. 2026;12(4):789-814. doi:10.3934/microbiol.2026034

BibTeX
@article{Mani2026,
  author = {Mani, Abishek and Kalangadan, Nashath and Magar, Sharayu and Sivaraj, Barath and Xavier, Gospel Gabriel and Diraviyam, Thirumalai and Sundaresan, Srivignesh and Govindarajan, Sutharsan and Rajaram, Kaushik},
  title = {Probiotic biogenics-mediated augmentation of phage therapy against multidrug-resistant Enterotoxigenic Escherichia coli},
  journal = {AIMS Microbiology},
  year = {2026},
  volume = {12},
  number = {4},
  pages = {789--814},
  doi = {10.3934/microbiol.2026034}
}
Kostenlos starten →